Bioxytran Inc. (OTCMKTS: BIXT) is perhaps one of the most undervalued biotechs in OTC. There is a real chance that if this...
Back in September, we published this piece covering BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). At the time, the company just picked up an expanded...
For a company that just picked up a major FDA approval, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is trading remarkably flat. Premarket on Thursday,...
Influenza is a big problem both domestically in the US and globally. There’s a massive infrastructure in place to try and combat...